I read it again.
These are my summary:
1. Growth opportunities: USA, UK and China
2. US listing is parallel with HK Listing
3. CFDA by 2nd half of 2019.
4. HK listing by Q1 2020.
Someone correct me if my understanding is wrong.
Conclusion: Provided there will be no further delay, We will see 50 cents soon and 1 dollar next year.
- Forums
- ASX - By Stock
- GMV
- Ann: Company Update
Ann: Company Update, page-117
-
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online